• Saba Imtiaz
  • Neelam Siddiqui


Background: Serum levels of vitamin-D are low in breast cancer patients. Vitamin-D levels have inverse correlations with postmenopausal state, obesity, poor sun exposure and low intake of vitamin-D rich diet. The objective of this study was to quantify levels of vitamin-D in serum to determine the degree of vitamin-D deficiency in breast cancer patients compared with age matched controls and to observe the association between serum 25-OH vitamin-D levels and personal and social parameters, BMI, amount of sun exposure and dietary intake. Methods: In this cross-sectional analytical study all newly diagnosed breast cancer female patients were recruited into the study over a period of 6 months. Age matched healthy females were also recruited as a control group. Personal and social data was documented on to a pro forma. Sun exposure was determined by mid-day exposure to direct sunlight. Serum 25-OHD levels were studied by ELISA technique on the blood samples. The dietary information was collected by recall over the last 1 year. Results: Vitamin-D deficiency was found in 99% breast cancer females and 90% in healthy females. Mean serum vitamin-D level was 9.6±5 ng/ml and 15.2±10 ng/ml for cases and control group respectively. All breast cancer and 95% healthy females with BMI >30 were found to be vitamin-D deficient. Menopausal state, parity, parda (veil) observation, area of living and sun exposure did not affect vitamin-D status in either group. Egg, fish and cheese intake revealed correlation with vitamin-D deficiency. Forty percent healthy females were found to have deficient serum vitamin-D levels despite being on supplement. Conclusion: Vitamin-D deficiency was highly prevalent among breast cancer females. Serum 25 OHD levels exhibited an inverse correlation with high body mass index and vitamin-D rich diet.Keywords: Vitamin-D deficiency, breast cancer, 25-OHD, sun exposure, body mass index


Bray F, McCarron P, Parkin DM. The changing global patterns of female breast cancer incidence and mortality. Breast Cancer Res 2004;6:229–39.

Gilani GM, Kamal S, Akhter AS. A differential study of breast cancer patients in Punjab, Pakistan. J Pak Med Assoc 2003;53:478–81.

Khan KA, Akram J, Fazal M. Hormonal actions of vitamin-D and its role beyond just being a vitamin: A review article. Int J Med Sci 2011;3(3):65–72.

Garland CF, Gorham ED, Mohr SB, Garland FC. Vitamin-D for cancer prevention: global perspective. Ann Epidemiol 2009;19:468–83.

Sheikh A, Saeed Z, Jafri SAD, Yazdani I, Hussain SA. Vitamin-D levels in asymptomatic adults--a population survey in Karachi, Pakistan. PLoS One 2012;7:e33452.

Masood SH, Iqbal MP. Prevalence of vitamin-D deficiency in South Asia. Pak J Med Sci 2008;24:891–7.

Crew KD, Gammon MD, Steck SE, Hershman DL, Cremers S, Dworakowski E, et al. Association between plasma 25-hydroxyvitamin-D and breast cancer risk. Cancer Prev Res (Phila) 2009;2:598–604.

Bertone-Johnson ER, Chen WY, Holick MF, Hollis BW, Colditz GA, Willett WC,et al. Palsma 25-hydoxyvitamin-D and 1,25-hydroxyvitamin-D and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 2005;14:1991–7.

Hatse S, Lambrechts D, Verstuyf A, Smeets A, Brouwers B, Vandorpe T, et al. Vitamin-D status at breast cancer diagnosis: correlation with tumor characteristics, disease outcome, and genetic determinants of vitamin-D insufficiency. Carcinogenesis 2012;33:1319–26.

Vrieling A, Hein R, Abbas S, Schneeweiss A, Flesch-Janys D, Chang-Claude J. Serum 25-hydroxy vitamin-D and postmenopausal breast cancer survival: a prospective patient cohort study. Breast Cancer Res 2011;13(4):R74.

Chen WY, Bertone-Johnson ER, Hunter DJ, Willett WC, Hankinson SE. Association between polymorphisms in the vitamin-D receptor and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2005:14:2335–9.

Holick MF. Vitamin-D deficiency. N Engl J Med 2007;357:266–81.

Wolpowitz D, Gilchrest BA. The vitamin-D questions: how much do you need and how should you get it? J Am Acad Dermatol 2006;54:301–17.

Ardawi MS, Qari MH, Rouzi AA, Maimani AA, Raddadi RM. Vitamin-D status in relation to obesity, bone mineral density, bone turnover markers and vitamin-D receptor genotypes in healthy Saudi pre- and postmenopausal women. Osteoporos Int. 2011;22:463–75.

Botella-Carretero JI, Alvarez-Blasco F, Villafruela JJ, Balsa JA, Vázquez C, Escobar-Morreale HF. Vitamin-D deficiency is associated with the metabolic syndrome in morbid obesity. Clin Nutr 2007;26:573–80.

Robien K, Cutler GJ, Lazovich D. Vitamin-D intake and breast cancer risk in postmenopausal women: the Iowa Women’s Health Study. Cancer Causes Control 2007; 18:775–82.

Khan QJ, Kimler BF, Fabian CJ. The Relationship between Vitamin-D and Breast Cancer Incidence and Natural History. Curr Oncol Rep 2010;12:136–42.

Carmichael AR, Bates T. Obesity and breast cancer: a review of the literature. Breast 2004;13(2):85–92.

Shin MH, Holmes MD, Hankinson SE, Wu K, Colditz GA, Willett WC. Intake of Dairy Products, Calcium, and Vitamin-D and Risk of Breast Cancer. J Natl Cancer Inst 2002; 94:1301–11.



Most read articles by the same author(s)

1 2 > >>